Your browser doesn't support javascript.
loading
Aspacytarabine for the treatment of patients with AML unfit for intensive chemotherapy: a phase 2 study.
Altman, Jessica K; Zuckerman, Tsila; Koprivnikar, Jamie; McCloskey, James; Kota, Vamsi; Keng, Michael; Frankfurt, Olga; Abaza, Yasmin; Bixby, Dale L; Emadi, Ashkan; Burch, Micah; Bhatnagar, Bhavana; Luger, Selina M; Percival, Mary-Elizabeth; Wolach, Ofir; Craig, Michael; Ganzel, Chezi; Roboz, Gail; Levi, Itai; Gourevitch, Anna; Flaishon, Liat; Tessler, Shoshi; Blumberg, Chen; Gengrinovitch, Stela; Ben Yakar, Ruth; Rowe, Jacob M.
Afiliação
  • Altman JK; Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL.
  • Zuckerman T; Department of Hematology and Bone Marrow Transplantation, Rambam Medical Center, Haifa, Israel.
  • Koprivnikar J; John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, NJ.
  • McCloskey J; John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, NJ.
  • Kota V; Georgia Cancer Center, Augusta University, Augusta, GA.
  • Keng M; University of Virginia Cancer Center-Charlottesville, Charlottesville, VA.
  • Frankfurt O; Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL.
  • Abaza Y; Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL.
  • Bixby DL; University of Michigan Comprehensive Cancer Center, Ann Arbor, MI.
  • Emadi A; University of Maryland School of Medicine, College Park, MD.
  • Burch M; Baylor Scott & White Research Institute, Dallas, TX.
  • Bhatnagar B; Arthur G James Cancer Hospital Comprehensive Cancer Center, The Ohio State University, Columbus, OH.
  • Luger SM; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.
  • Percival ME; University of Washington and Fred Hutchinson Cancer Center, Seattle, WA.
  • Wolach O; Department of Hematology, Rabin Medical Center, Petah Tikva, Israel.
  • Craig M; Internal Medicine, Hematology-Oncology, West Virginia University, Morgantown, WV.
  • Ganzel C; Shaare Zedek Medical Center, Jerusalem, Israel.
  • Roboz G; Department of Hematology/Oncology, Weill Cornell Medical College, New York City, NY.
  • Levi I; Soroka University Medical Center, Beersheba, Israel.
  • Gourevitch A; Soroka University Medical Center, Beersheba, Israel.
  • Flaishon L; Biosight Ltd, Tel-Aviv, Israel.
  • Tessler S; Biosight Ltd, Tel-Aviv, Israel.
  • Blumberg C; Biosight Ltd, Tel-Aviv, Israel.
  • Gengrinovitch S; Biosight Ltd, Tel-Aviv, Israel.
  • Ben Yakar R; Biosight Ltd, Tel-Aviv, Israel.
  • Rowe JM; Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.
Blood Adv ; 7(24): 7494-7500, 2023 12 26.
Article em En | MEDLINE | ID: mdl-37903324
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndromes Mielodisplásicas / Leucemia Mieloide Aguda Limite: Aged / Humans Idioma: En Revista: Blood Adv Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Israel
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndromes Mielodisplásicas / Leucemia Mieloide Aguda Limite: Aged / Humans Idioma: En Revista: Blood Adv Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Israel